The tumor tissue alaysis demonstrated the greatest differences relative to two other tissues in the liposomal combination therapy group (Lip-EPA + Lip-gp100) in the number of the CD4 + T cells over monotherapy and non-liposomal EPA + gp100 groups (Fig. 4B). This evidence concerns the gene PMEL and neoplasm.